Therefore, our data suggested an important role of gal-1 in CD133+ lung cancer stem cells, which might be a potential target for treatment of lung adenocarcinoma and a marker for prognosis of lung cancer patients. The gene discussed is LGALS1; the disease is lung carcinoma.